Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics

Following the obviation of the pathogen safety threats posed by previous generations of clotting factor concentrates for the treatment of hemophilia, the principal issue facing the patient community is timely access to adequate supplies of continuously improving therapies. The application of evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrugia, Albert, Noone, Declan, Schlenkrich, Uwe, Schlenkrich, Steffen, O’Mahony, Brian, Cassar, Josephine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476485/
https://www.ncbi.nlm.nih.gov/pubmed/26124687
http://dx.doi.org/10.2147/JBM.S79091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476485/
https://www.ncbi.nlm.nih.gov/pubmed/26124687
http://dx.doi.org/10.2147/JBM.S79091

Ejemplares similares